HPV post-infection microenvironment and cervical cancer

被引:156
作者
Yuan, Yi [1 ,2 ]
Cai, Xushan [3 ]
Shen, Fangrong [4 ]
Ma, Feng [1 ]
机构
[1] Suzhou Inst Syst Med, Suzhou 215123, Peoples R China
[2] Tongji Univ, Shanghai Tongji Hosp, Sch Med, Dept Lab Med, Shanghai 200065, Peoples R China
[3] Maternal & Child Hlth Hosp Jiading Dist, Dept Clin Lab, Shanghai 201821, Peoples R China
[4] Soochow Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Suzhou 215001, Peoples R China
基金
中国国家自然科学基金;
关键词
Papillomaviruses; Sexually transmitted virus; HPV infection; Immune regulation; PIM; PAPILLOMAVIRUS TYPE-16 E6; HIGH-RISK HPV; E7; ONCOPROTEINS; IMMUNE EVASION; IFN-GAMMA; DIFFERENTIALLY MODULATE; PERIPHERAL-BLOOD; CELLULAR REDOX; E2; PROTEIN; E-CADHERIN;
D O I
10.1016/j.canlet.2020.10.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Human papillomavirus (HPV) is the most common sexually transmitted virus worldwide. More than 99% of cervical cancer cases are associated with certain types of HPVs, termed high-risk types. In addition to the wellknown transformative properties, HPVs-infected cells actively instruct the local milieu and create a supportive post-infection microenvironment (PIM), which is becoming recognized as a key factor for the viral persistence, propagation, and malignant progression. The PIM is initiated and established via a complex interplay among virus-infected cells, immune cells, and host stroma, as well as their derived components including chemokines, cytokines, extracellular vesicles, and metabolites. In this review, we summarize the current understanding of these key components, characteristics, and effects of the PIM, and highlights the prospect of targeting the PIM as a potential strategy to improve therapeutic outcomes for cervical cancer.
引用
收藏
页码:243 / 254
页数:12
相关论文
共 129 条
[71]   The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α [J].
Li, SY ;
Labrecque, S ;
Gauzzi, MC ;
Cuddihy, AR ;
Wong, AHT ;
Pellegrini, S ;
Matlashewski, GJ ;
Koromilas, AE .
ONCOGENE, 1999, 18 (42) :5727-5737
[72]   Navigating metabolic pathways to enhance antitumour immunity and immunotherapy [J].
Li, Xiaoyun ;
Wenes, Mathias ;
Romero, Pedro ;
Huang, Stanley Ching-Cheng ;
Fendt, Sarah-Maria ;
Ho, Ping-Chih .
NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (07) :425-441
[73]   Microbiome factors in HPV-driven carcinogenesis and cancers [J].
Lin, Daniel ;
Kouzy, Ramez ;
Jaoude, Joseph Abi ;
Noticewala, Sonal S. ;
Medrano, Andrea Y. Delgado ;
Klopp, Ann H. ;
Taniguchi, Cullen M. ;
Colbert, Lauren E. .
PLOS PATHOGENS, 2020, 16 (06)
[74]   Nuclear lactate dehydrogenase A senses ROS to produce α-hydroxybutyrate for HPV-induced cervical tumor growth [J].
Liu, Yuan ;
Guo, Ji-Zheng ;
Liu, Ying ;
Wang, Kui ;
Ding, Wencheng ;
Wang, Hui ;
Liu, Xiang ;
Zhou, Shengtao ;
Lu, Xiao-Chen ;
Yang, Hong-Bin ;
Xu, Chenyue ;
Gao, Wei ;
Zhou, Li ;
Wang, Yi-Ping ;
Hu, Weiguo ;
Wei, Yuquan ;
Huang, Canhua ;
Lei, Qun-Ying .
NATURE COMMUNICATIONS, 2018, 9
[75]   Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth [J].
Liu, Yuan ;
Murray-Stewart, Tracy ;
Casero, Robert A. ;
Kagiampakis, Ioannis ;
Jin, Lihua ;
Zhang, Jiawen ;
Wang, Huihui ;
Che, Qi ;
Tong, Huan ;
Ke, Jieqi ;
Jiang, Feizhou ;
Wang, Fangyuan ;
Wan, Xiaoping .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (06) :2011-2023
[76]  
Lo Cigno I., 2020, SUBVERSION HOST INNA, P9
[77]  
Lo Cigno I., 2020, J VIROL, V94
[78]   Oncogenes and tumor angiogenesis:: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner [J].
López-Ocejo, O ;
Viloria-Petit, A ;
Bequet-Romero, M ;
Mukhopadhyay, D ;
Rak, J ;
Kerbel, RS .
ONCOGENE, 2000, 19 (40) :4611-4620
[79]   A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer [J].
Lorusso, Domenica ;
Petrelli, Fausto ;
Coinu, Andrea ;
Raspagliesi, Francesco ;
Barni, Sandro .
GYNECOLOGIC ONCOLOGY, 2014, 133 (01) :117-123
[80]   Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFNγ- and TNFα-Mediated Antiproliferative Effects and Necroptosis [J].
Ma, Wenbo ;
Tummers, Bart ;
van Esch, Edith M. G. ;
Goedemans, Renske ;
Melief, Cornelis J. M. ;
Meyers, Craig ;
Boer, Judith M. ;
van der Burg, Sjoerd H. .
FRONTIERS IN IMMUNOLOGY, 2016, 7